广济药业：第十一届董事会第十四次（临时）会议决议公告

Group 1 - The company announced the approval of multiple resolutions during the 14th (temporary) meeting of the 11th Board of Directors, including the proposal to repurchase and cancel part of the restricted stock from the 2021 incentive plan [2] - The company also approved the proposal for the supplementary election of an independent director [2] - Additionally, the company passed resolutions to revise and establish certain governance systems [2]